With reference to CDSL’s Operating Instructions for Issuers/RTAs which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed, Panacea Biotec has informed that no share has been dematerialized during the month of March, 2024. The company has confirmed that the total number of shares dematerialized as on March 31, 2024, were as under: NSDL - 5,30,27,436, CDSL - 80,60,089 = 6,10,87,525 (Total). A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services, regarding shares dematerialized as on March 31, 2024 is also enclosed as Annexure - 1.
The above information is a part of company’s filings submitted to BSE.
